In anopen-label, randomized controlled clinical trial that included 112 patients, 12 weeks of increased whole-grain consumption significantly decreased the NAFLD grades, as well as theserum concentration of ALT, AST, GGTP, and the systolic and diastolic blood pressure [80]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.